Ewa Gorodkiewicz

MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Microcapsule-based biosensor containing catechol for the reagent-free inhibitive detection of benzoic acid by tyrosinase

Unleashing the therapeutic potential of human kallikrein-related serine proteases

The gut microbiome, diet, and links to cardiometabolic and chronic disorders

Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases

Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism

Structure and function of “metalloantibiotics”

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Breast Cancer Treatment

Review article: long‐term safety of nucleoside and nucleotide analogues in HBV‐monoinfected patients

Advances in Copper Complexes as Anticancer Agents

Recent advances in biosensors based on enzyme inhibition

Synthesis and Biological Activity of N-Sulfonyltripeptides with C-Terminal Arginine as Potential Serine Proteases Inhibitors

Cystatin C

The mechanism of Daunorubicin-induced inhibition of prolidase activity in human skin fibroblasts and its implication to impaired collagen biosynthesis

Surface Plasmon Resonance Imaging biosensor for cystatin determination based on the application of bromelain, ficin and chymopapain